MDR – Article 91 – Implementing acts

Article 91

1. The Commission may, by means of implementing acts, and after consultation of the MDCG, adopt the detailed arrangements and procedural aspects necessary for the implementation of Articles 85 to 90 and 92 as regards the following:

(a)the typology of serious incidents and field safety corrective actions
in relation to specific devices, or categories or groups of devices;
(b)the reporting of serious incidents and field safety corrective actions and field safety notices, and the provision of periodic summary
reports, post-market surveillance reports, PSURs and trend reports
by manufacturers as referred to in Articles 85, 86, 87, 88 and 89
respectively;
(c)standard structured forms for electronic and non-electronic
reporting, including a minimum data set for reporting of suspected
serious incidents by healthcare professionals, users and patients;
(d)timelines for the reporting of field safety corrective actions, and for
the provision by manufacturers of periodic summary reports and
trend reports, taking into account the severity of the incident to be
reported as referred to in Article 87;
(e)harmonised forms for the exchange of information between
competent authorities as referred to in Article 89;
(f)procedures for the designation of a coordinating competent
authority; the coordinated evaluation process, including tasks and
responsibilities of the coordinating competent authority and
involvement of other competent authorities in this process.

The implementing acts referred to in the first paragraph shall be adopted in accordance with the examination procedure referred to in Article 114(3).

MDR – Article 81 – Implementing acts

Article 81

Implementing acts

The Commission may, by means of implementing acts, establish the detailed arrangements and procedural aspects necessary for the implementation of this Chapter as regards the following:

(a)harmonised electronic forms for the application for clinical
investigations and their assessment as referred to in Articles 70 and78, taking into account specific categories or groups of devices;
(b)the functioning of the electronic system referred to in Article 73;
(c)harmonised electronic forms for the notification of PMCF
investigations as referred to in Article 74(1), and of substantial
modifications as referred to in Article 75;
(d)the exchange of information between Member States as referred to
in Article 76;
(e)harmonised electronic forms for the reporting of serious adverse
events and device deficiencies as referred to in Article 80;
(f)the timelines for the reporting of serious adverse events and device
deficiencies, taking into account the severity of the event to be
reported as referred to in Article 80;
(g)uniform application of the requirements regarding the clinical
evidence or data needed to demonstrate compliance with the
general safety and performance requirements set out in Annex I.

The implementing acts referred to in the first paragraph shall be adopted in accordance with the examination procedure referred to in Article 114(3).